Chemokines in rheumatic diseases

Research output: Contribution to journalReview article

61 Citations (Scopus)


Chemotactic cytokines, termed chemokines, mediate the ingress of leukocytes into the inflamed synovium. In this review, authors discuss the role of the most relevant chemokines and chemokine receptors involved in chronic inflammatory rheumatic diseases. Rheumatoid arthritis was chosen as a prototype to discuss these issues, as the majority of studies on the role of chemokines in inflammatory diseases were carried out in arthritis. However, other rheumatic diseases including systemic lupus erythematosus, systemic sclerosis, Sjögren's syndrome, mixed connective tissue disease, polymyositis /dermatomyositis, antiphospholipid syndrome and systemic vasculitides are also discussed in this context. Apart from discussing the pathogenic role of chemokines and their receptors, authors also review the regulation of chemokine production by other inflammatory mediators, as well as the important relevance of chemokines for antirheumatic therapies.

Original languageEnglish
Pages (from-to)91-102
Number of pages12
JournalCurrent drug targets
Issue number1
Publication statusPublished - Jan 1 2006



  • Biological therapy
  • Chemokine receptors
  • Chemokines
  • Rheumatic diseases
  • Rheumatoid arthritis
  • Synovial tissue

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this